Considerations for enhanced mesenchymal stromal/stem cell myogenic commitment in vitro

Show simple item record

dc.contributor.author Grobbelaar, Simone
dc.contributor.author Mercier, Anne Elisabeth
dc.contributor.author Van den Bout, Iman
dc.contributor.author Durandt, Chrisna
dc.contributor.author Pepper, Michael Sean
dc.date.accessioned 2024-01-26T08:55:00Z
dc.date.available 2024-01-26T08:55:00Z
dc.date.issued 2024-01
dc.description.abstract The generation of tissue from stem cells is an alluring concept as it holds a number of potential applications in clinical therapeutics and regenerative medicine. Mesenchymal stromal/stem cells (MSCs) can be isolated from a number of different somatic sources, and have the capacity to differentiate into adipogenic, osteogenic, chondrogenic, and myogenic lineages. Although the first three have been extensively investigated, there remains a paucity of literature on the latter. This review looks at the various strategies available in vitro to enhance harvested MSC commitment and differentiation into the myogenic pathway. These include chemical inducers, myogenic-enhancing cell culture substrates, and mechanical and dynamic culturing conditions. Drawing on information from embryonic and postnatal myogenesis from somites, satellite, and myogenic progenitor cells, the mechanisms behind the chemical and mechanical induction strategies can be studied, and the sequential gene and signaling cascades can be used to monitor the progression of myogenic differentiation in the laboratory. Increased understanding of the stimuli and signaling mechanisms in the initial stages of MSC myogenic commitment will provide tools with which we can enhance their differentiation efficacy and advance the process to clinical translation. en_US
dc.description.department Immunology en_US
dc.description.department Physiology en_US
dc.description.librarian hj2024 en_US
dc.description.sdg None en_US
dc.description.sponsorship The South African Medical Research Council in terms of the SAMRC's Flagship Award Project, the SAMRC Extramural Unit for Stem Cell Research and Therapy, and the Institute for Cellular and Molecular Medicine of the University of Pretoria. en_US
dc.description.uri http://www.cts-journal.com en_US
dc.identifier.citation Grobbelaar, S., Mercier, A.E., Van den Bout, I., Durandt, C. & Pepper, M.S. Considerations for enhanced mesenchymal stromal/stem cell myogenic commitment in vitro. Clinical and Translational Science 2024; 17: e13703. doi: 10.1111/cts.13703. en_US
dc.identifier.issn 1752-8054 (print)
dc.identifier.issn 1752-8062 (online)
dc.identifier.other 10.1111/cts.13703
dc.identifier.uri http://hdl.handle.net/2263/94111
dc.language.iso en en_US
dc.publisher Wiley en_US
dc.rights © 2023 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License. en_US
dc.subject Mesenchymal stromal/stem cells (MSCs) en_US
dc.subject In vitro en_US
dc.title Considerations for enhanced mesenchymal stromal/stem cell myogenic commitment in vitro en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record